Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from New Tools for Optimizing Theranostic Implementation

  • You have access
    Preliminary Dosimetry Results from a First-in-Human Phase I Study Evaluating the Efficacy and Safety of [225Ac]-FPI-1434 in Patients with IGF-1R Expressing Solid Tumors
    Daniel Juneau, Fred Saad, Alejandro Berlin, Ur Metser, Igor Puzanov, Dominick Lamonica, Richard Sparks, Eric Burak, Ryan Simms, John Rhoden, Lauren Creeden, Courtney Watson, Thomas Armor, Julia Kazakin, James O'Leary, Jean-Mathieu Beauregard and Maxime Chenard-Poirier
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 74;
  • You have access
    A custom-made platform for radiopeptide optimization and dose on demand radiosynthesis
    Zhiguo Liu, Kai Cheng and Zheng Fu
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 70;
  • You have access
    Feasibility of Machine Learning-Assisted Personalized Dosimetry for Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia; a Phase III Clinical trial
    Roberto Fedrigo, John Harpel, Vijay Reddy, Mark Berger, Arman Rahmim, Carlos Uribe and Qing Liang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 73;
  • You have access
    Experimental study on the production of Ac-225 using an electron linear accelerator
    Takahiro Tadokoro, Yuichiro Ueno, Yuko Kani, Makiko Shimada, Takahiro Sasaki, Takahiro Watanabe, Hidetoshi Kikunaga, Shigeru Kashiwagi, Makoto Inagaki, Shun Sekimoto and Tsutomu Ohtsuki
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 68;
  • You have access
    Clinical production of >100mCi of [68Ga]Ga-PSMA-11 via dual target cyclotron irradiation
    Melissa Rodnick, Katie Gagnon, David Parr and Peter Scott
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 69;
  • You have access
    Albumin Binders for Tumor Enhanced FAPI Radioligand Retention
    Mengxin Xu, Jie Ding, Pu Zhang, Junyi Chen and Zhibo Liu
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 72;
  • You have access
    Integrating deep-learning based segmentation and ‘fast’ voxel-level dosimetry tools to enable automated real-time patient specific dosimetry
    David Mirando, Yuni Dewaraja, Jeremy Niedbala, Scott Wilderman and Aaron Nelson
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 75;
  • You have access
    Semiconducting polymers enhance Cerenkov radiation energy transfer for multimodal cancer theranostics
    Zachary Rosenkrans, Dalong NI, Kaelyn Becker, Eduardo Aluicio-Sarduy, Jonathan Engle and Weibo Cai
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 71;
SNMMI

© 2025 SNMMI

Powered by HighWire